PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Hemistepsin A ameliorates acute inflammation in macrophages via inhibition of nuclear factor-kappaB and activation of nuclear factor erythroid 2-related factor 2.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29129664 ↗2017Reported benefit

Hemistepsin A ameliorates acute inflammation in macrophages via inhibition of nuclear factor-kappaB and activation of nuclear factor erythroid 2-related factor 2.

MouseChemical/toxin

Model: D-galactosamine plus lipopolysaccharide induced acute liver injury in mice, with supporting in vitro work in RAW 264.7 macrophages and primary Kupffer cells

Hemistepsin A reduced nitric oxide, iNOS and COX-2 expression and proinflammatory cytokine secretion in Toll-like receptor ligand stimulated macrophages and Kupffer cells. In the D-galactosamine/LPS liver injury model it lessened hepatocyte degeneration and inflammatory cell infiltration and reduce…

Extraction: extract · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.